Related references
Note: Only part of the references are listed.Role of C-Reactive Protein at Sites of Inflammation and Infection
Nicola R. Sproston et al.
FRONTIERS IN IMMUNOLOGY (2018)
Management of Benign Prostatic Hyperplasia
Eric H. Kim et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms
Jay H. Fowke et al.
PLOS ONE (2016)
Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study
Kathleen C. Torkko et al.
JOURNAL OF UROLOGY (2015)
Prevalence of Inflammation and Benign Prostatic Hyperplasia on Autopsy in Asian and Caucasian Men
Alexandre R. Zlotta et al.
EUROPEAN UROLOGY (2014)
Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Associations Between C-Reactive Protein and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom Outcomes in a Population-based Cohort
Jennifer L. St. Sauver et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Evaluation of Interleukin-8 in Expressed Prostatic Secretion as a Reliable Biomarker of Inflammation in Benign Prostatic Hyperplasia
Liangren Liu et al.
UROLOGY (2009)
The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial
J. Curtis Nickel et al.
EUROPEAN UROLOGY (2008)
Histologic Influence of Doxazosin and Finasteride in Benign Prostatic Hyperplasia Accompanying Chronic Inflammation
Dong Soo Park et al.
UROLOGIA INTERNATIONALIS (2008)
Prevalence and characteristics of lower urinary tract symptoms in men aged ≥80 years
J. Kellogg Parsons et al.
UROLOGY (2008)
Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
Vibhash C. Mishra et al.
BJU INTERNATIONAL (2007)
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Gero Kramer et al.
EUROPEAN UROLOGY (2007)
Seminal plasma cytokines and chemokines in prostate inflammation: Interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia
Giuseppe Penna et al.
EUROPEAN UROLOGY (2007)
Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells
E Kibayashi et al.
CLINICAL SCIENCE (2005)
Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III)
S Rohrmann et al.
PROSTATE (2005)
Share Paper
